At the Company's Annual Meeting of Stockholders held on June 7, 2012, the stockholders considered and approved three proposals, each of which is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 19, 2012 for the Annual Meeting of Stockholders.

The results detailed below represent the final voting results as certified by the Inspector of Elections:

Proposal 1

The stockholders elected the following seven directors to hold office until the 2013 Annual Meeting of Stockholders: Howard G. Berger, M.D.; Marvin S. Cadwell; John V. Crues, III, M.D.; Norman R. Hames; Lawrence L. Levitt; Michael L. Sherman, M.D.; and David L. Swartz, based on the following votes:

Director                      For       Withheld    Broker Non-Votes
Howard G. Berger, M.D.     21,193,885     858,229         11,463,825
Marvin S. Cadwell          21,168,416     883,698         11,463,825
John V. Crues, III, M.D.   20,570,347   1,481,767         11,463,825
Norman R. Hames            20,699,666   1,352,448         11,463,825
Lawrence L. Levitt         21,164,361     887,753         11,463,825
Michael L. Sherman, M.D.   21,168,621     883,493         11,463,825
David L. Swartz            21,160,498     891,616         11,463,825

Proposal 2

The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2012 was ratified based on the following votes:

For Against Abstentions
33,178,802 284,942 52,195

Proposal 3

The advisory (non-binding) vote on the compensation of the Company's named executive officers was approved based on the following votes:

For Against Abstentions Broker Non-Votes 21,401,658 517,570 132,886 11,463,825